Evaluation of dopamine D-2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride

Neuropsychopharmacology

Volumn 25, Issue 4, 2001, Pages 476-488

  Mukherjee, Jogeshwar ^a,b   Christian, Bradley T ^a   Narayanan, Tanjore K ^a   Shi, Bingzhi ^a   Mantil, Joseph ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

18F Fallypride; Dopamine D 2 Receptors; Neuroleptics; Occupancy; PET

Indexed keywords

CLOZAPINE; DOPAMINE 2 RECEPTOR; FALLYPRIDE; FLUORINE 18; HALOPERIDOL; NEUROLEPTIC AGENT; RADIOLIGAND; RISPERIDONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG BINDING; DRUG DISCRIMINATION; DRUG EFFECT; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RAT; RECEPTOR OCCUPANCY; RHESUS MONKEY; THALAMUS;

ANIMALS; ANTIPSYCHOTIC AGENTS; AUTORADIOGRAPHY; BENZAMIDES; BRAIN; CLOZAPINE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORINE RADIOISOTOPES; HALOPERIDOL; MACACA MULATTA; MALE; NEOSTRIATUM; PYRROLIDINES; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RISPERIDONE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034850353     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(01)00251-2     Document Type: Article

References (41)

1. Do novel antipsychotics have similar pharmacological characteristics? A review of evidence
2. Tissue concentrations of clozapine and its metabolites in the rat
3. High occupancy of D-2 dopamine receptor by high doses of clozapine in the primate brain
4. Quantitation of striatal and extrastriatal dopamine D-2 receptors using PET imaging of F-18 fallypride in nonhuman primates
5. Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach
6. D-1, D-2, and 5HT-2 receptor occupancy in clozapine-treated patients
7. A PET study of 11C-FLB 457 binding to extrastriatal D-2 dopamine receptors in healthy subjects and antipsychotic drug-related patients
8. Measuring dopamine transporter occupancy by cocaine in vivo: Radiotracer considerations
9. Kinetic and equilibrium analyses of 123I-epidepride binding to striatal and extrastriatal dopamine D2 receptors
10. Complete conversion of brain D-2 dopamine receptors from the high- to low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide
11. The concept of the ventral striatum in nonhuman primates
12. Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using 125I-epidepride
13. Distribution of D-1 and D-2 dopamine receptors and dopamine and its metabolites in the human brain
14. The accumbens: Beyond the core-shell dichotomy
15. Transient occupancy at the D2 receptor - A new hypothesis for atypical antipsychotics
16. A positron emission tomography study of quetiapine in schizophrenia
17. Clinical and theoretical implications of 5HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia
18. Identification of extrastriatal dopamine D-2 receptors in post-mortem human brain with 125I-epidepride
19. IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol
20. Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review
21. Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: Role of 5HT2 receptors
22. Graphical analysis of reversible radioligand binding from time-activity measurement applied to [N-11C-methyl]-(-)cocaine PET studies in human subjects
23. Distribution volume ratios without blood sampling from graphical analysis and PET data
24. The mechanism of action of novel antipsychotic drugs
25. An overview of the mechanism of action of clozapine
26. 18F-fallypride in non-human primates using positron emission tomography
27. 18F-fallypride
28. Nonequipotent doses partly explain differences among antipsychotics - Implications of PET studies
29. Individual variation in D-2 dopamine receptor occupancy in clozapine-treated patients
30. Limbic selectivity of clozapine
31. Atypical antipsychotics: Are some more atypical than others?
32. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia
33. Update on the clinical efficacy and side effects of clozapine
34. Dopaminergic approaches to antipsychotic agents
35. A clinical guide to antipsychotics
36. Atypical neuroleptics have low affinity for dopamine D-2 receptors or are selective for D-4 receptors
37. Dopamine D-2 receptor binding sites for agonists: A tetrahedral model
38. Rapid release of antipsychotic drugs from dopamine D-2 receptors: An explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine
39. Dopamine receptors and antipsychotic drug response
40. Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D2 receptors
41. Dopamine D-2 and D-4 receptor ligands: Relation to antipsychotic action